AlphaStocks
6.9
Consider Buy

Harmony Biosciences Holdings, Inc. (HRMY)

Health Care / Biotechnology

S&P SmallCap 600

$27.94

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#114out of 1127 in Health Care

Is Harmony Biosciences Holdings, Inc. a Good Investment in 2026?

Harmony Biosciences Holdings, Inc. (HRMY) scores 6.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates Harmony Biosciences Holdings, Inc. as Strong. The Lynch model is the least favorable, rating it Attractive. Harmony Biosciences Holdings, Inc. ranks #114 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E10.3ROE18.6Market Cap2B

Valuation

Trades at 10x earnings — near sector median of 25x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Strong

Business quality & competitive moat

Graham

Attractive

10% below fair value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Strong

Top 25% (rank 16%)

Frequently Asked Questions

Is Harmony Biosciences Holdings, Inc. (HRMY) a good investment?
Based on AlphaStocks' composite analysis, Harmony Biosciences Holdings, Inc. (HRMY) scores 6.9 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trades at 10x earnings — near sector median of 25x.
What is Harmony Biosciences Holdings, Inc.'s Piotroski F-Score?
Harmony Biosciences Holdings, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HRMY overvalued or undervalued?
A precise fair value estimate is not available for HRMY. Trades at 10x earnings — near sector median of 25x.
How does HRMY compare to other Health Care stocks?
Harmony Biosciences Holdings, Inc. ranks #114 out of 1127 stocks in the Health Care sector, placing it in the top 10% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about HRMY?
AlphaStocks evaluates HRMY using five proven investment models. Piotroski: Attractive; Buffett: Strong; Graham: Attractive; Lynch: Attractive; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.9/10.

Similar Stocks

PARRFTIAZN

Compare HRMY with

HRMY vs PARRHRMY vs FTIHRMY vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer